Top insider buys: Mar 15 – Mar 21, 2021

The largest open-market purchases company insiders reported on SEC Form 4 between Mar 15 – Mar 21, 2021.

Week 11, 2021

#CompanyWho boughtSharesValueSource
1PFSI

PennyMac Financial Services, Inc.

2 officers/directors

Cluster buy

MFN Partners, LP, Farhad Nanji

194,198

$12.7M

SEC filings
2MRKR

Marker Therapeutics, Inc.

4 officers/directors

Cluster buy

Paul Edward Walker, Peter W. Sonsini, Scott D. Sandell, Joshua Makower, Mohamad Makhzoumi, Anthony A. Florence Jr., Carmen Chang, Ali Behbahani, Forest Baskett, New Enterprise Associates 16, L.P., John Robert Wilson, Juan Vera, Peter L. Hoang, Steve Elms

3,571,427

$6.2M

+$100.0M by large holders

SEC filings
3Owl Rock Technology Finance Corp.

3 officers/directors

Cluster buy

Douglas I. Ostrover, Craig Packer, Alan Kirshenbaum

355,872

$5.5M

SEC filings
4MBIN

Merchants Bancorp

4 officers/directors

Cluster buy

Anne E. Sellers, Patrick D. O'Brien, Andrew Juster, Susan Dehner Kucer

204,000

$5.1M

SEC filings
5GOCO

GoHealth, Inc.

3 officers/directors

Cluster buy

Brandon M. Cruz, Clinton P. Jones, Anita Pramoda

366,370

$4.2M

SEC filings
6MYE

MYERS INDUSTRIES INC

2 officers/directors

Cluster buy

Jeffrey Kramer, Ronald M. Defeo

20,000

$396K

SEC filings
7KIDS

ORTHOPEDIATRICS CORP

2 officers/directors

Cluster buy

David R. Pelizzon, Harold Ruf

6,580

$307K

SEC filings
8KNWN

KNOW LABS, INC.

2 officers/directors

Cluster buy

William Arthur Owens, Jon Pepper

112,500

$225K

SEC filings
9FOX

Fox Corp

Chairman

Keith Rupert Murdoch

500,000

$21.4M

SEC filings
10ARMP

Armata Pharmaceuticals, Inc.

Director

Innoviva, Inc.

4,285,935

$13.9M

SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.